Intraarterial infusion of autologous lymphocytes for the treatment of refractory lymphoedema. Preliminary report.
To evaluate the results of the treatment of lymphoedema by intra-arterial infusion of autologous lymphocytes. Open study. University Hospital. 13 patients with refractory lymphoedema. Lymphocytes were separated from the patient's own blood using a blood cell separator; about 100 cc of lymphocyte dominant blood separated from this blood was immediately infused into the proximal artery of the affected limb. Infusion was practiced once a week, and repeated 4 to 6 times. Change in size of the affected limb (defined as the difference between the affected limb and the normal limb after treatment), and softening of the edema (measured with a tension gauge). In all 13 patients there was softening of the affected hard limb followed by a reduction in the size of the limb (mean 64%), and the ache and sensation of heat in the limb lessened. The reduction in size was maintained in 9 of the 13 patients for three months, despite returning to their normal activities. Intra-arterial infusion of autologous lymphocytes is a promising treatment for refractory lymphoedema.